Top Markets
Coin of the day
Epigenomics AG Epigenomics AG

Epigenomics AG

ECX
Rankning i aktier #38936
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
Aktiekurs
$0.83030862
Senast synkroniserad: 2024-06-27
Marknadsvärde
$726.64K
Förändring (1 dag)
-1.35%
Förändring (1 år)
0.00%
Land
DE
Handel Epigenomics AG (ECX)

Kategori

Historik för aktiesplit för Epigenomics AG (ECX)
Aktien Epigenomics AG (symbol: ECX) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 14, 2026.
En ECX-aktie köpt före Aug 14, 2026 motsvarar nu 0 ECX-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
8 x34
US
7 x47
US
0 -
CN
0 -
US
4 x15
US